IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Return
65.21%
This Quarter Return
+14.89%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$283M
AUM Growth
+$42.6M
(+18%)
Cap. Flow
+$49.2M
Cap. Flow
% of AUM
17.35%
Top 10 Holdings %
Top 10 Hldgs %
54.99%
Holding
128
New
25
Increased
11
Reduced
19
Closed
34
Top Buys
| 1 |
SLRN
ACELYRIN
SLRN
|
$61M |
| 2 |
IDEAYA Biosciences
IDYA
|
$11.5M |
| 3 |
Nuvalent
NUVL
|
$11.5M |
| 4 |
Disc Medicine
IRON
|
$10.7M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$8.56M |
Top Sells
Sector Composition
| 1 | Healthcare | 97.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Replimune Group
REPL
$494M
| – | – |
0
| – | – |
|
|
SAGE
127
DELISTED
Sage Therapeutics
SAGE
| – | – |
-17,805
| Closed | -$747K |
|
128
Sarepta Therapeutics
SRPT
$1.96B
| – | – |
-8,324
| Closed | -$1.15M |
|